Pandemic akin to war, lawyer tells Covid inquiry
Decisions were “finely balanced” and, with hindsight, might have been different, Fiona Scolding KC says.
Similar Posts
Matt Hancock says UK’s pandemic strategy was completely wrong
Planning focused more on burying the dead than averting disaster, ex-health secretary says.
7 Things Stroke Doctors Say You Should Never, Ever Do
In the United States, strokes are a top cause of death and a major cause of disability, according to the American Stroke Association. This is a scary reality, especially since many of the stroke risk factors are pretty silent (like high cholesterol and high blood pressure) ― until they’re not. But just because some of…
6 Stupid Holiday Food ‘Rules’ That Are Really Diets In Disguise
It’s the most wonderful time of the year ― unless you’re on a diet and have set impossible standards for eating during the holidays. There’s nothing wrong with taking an “everything in moderation” approach at the dinner table, but other “rules” we establish for ourselves around the holidays can actually hinder rather than help our…
Ozempic, other weight-loss drugs may strengthen New Year’s resolutions, experts say: Health goal ‘boost’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Covid Inquiry: Abuse of experts must stop, says Whitty
Sir Chris laments treatment as he gives evidence to Covid Inquiry on pandemic preparedness.
MoonLake Immunotherapeutics explores sale | Reuters News Agency
Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…
